Skip to content
Catalyst

PapersPMID:25015735

Postprandial glucose-lowering effects of fermented red ginseng in subjects with impaired fasting glucose or type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial.

BMC complementary and alternative medicine2014The record ↗

findings
5
compound
1
endpoints
5
PMID:25015735
  1. Finding, moderate evidenceno difference foundHDL cholesterol
  2. Finding, moderate evidenceno difference foundLDL cholesterol
  3. Finding, moderate evidenceno difference foundFasting blood glucose
  4. Finding, moderate evidenceno difference foundTotal cholesterol (TC)
  5. Finding, moderate evidenceno difference foundTriglycerides
Study, every finding
RCT · 42 participants · 4 weeks
Dose studied, every finding
three FRG capsules per day (2.7 g per day) for four weeks
Population, every finding
Adults aged 20 to 75 years with impaired fasting glucose, impaired glucose tolerance or newly diagnosed type 2 diabetes (fasting glucose 5.6 to 7.8 mmol/l) not on glucose-lowering drugs, intention-to-treat

No finding here moved its endpoint.

Study record

Design
randomised controlled trial
Species
human
Population
Adults aged 20-75 years with impaired fasting glucose, impaired glucose tolerance or type 2 diabetes (not on glucose-lowering therapy); fermented red ginseng extract of Panax ginseng C.A. Meyer (steamed, ethanol-extracted, fermented with Lactobacillus plantarum)
Participants
42
Comparator
placebo
Duration
28 days
Endpoints measured
13